Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor.
Inactivation of von Hippel-Lindau tumor-suppressor protein (pVHL) is associated with von Hippel-Lindau disease, an inherited cancer syndrome, as well as the majority of patients with sporadic clear cell renal cell carcinoma (RCC). Although the involvement of pVHL in oxygen sensing through targeting hypoxia-inducible factor-α subunits to ubiquitin-dependent proteolysis has been well documented, less is known about pVHL regulation under both normoxic and hypoxic conditions. We found that pVHL levels decreased in hypoxia and that hypoxia-induced cell cycle arrest is associated with pVHL expression in RCC cells. pVHL levels fluctuate during the cell cycle, paralleling cyclin B1 levels, with decreased levels in mitosis and G1. pVHL contains consensus destruction (D) box sequences, and pVHL associates with Cdh1, an activator of the anaphase-promoting complex/cyclosome (APC/C) E3 ubiquitin ligase. We show that pVHL has a decreased half-life in G1, Cdh1 downregulation results in increased pVHL expression, whereas Cdh1 overexpression results in decreased pVHL expression. Taken together, these results suggest that pVHL is a novel substrate of APC/C(Cdh1). D box-independent pVHL degradation was also detected, indicating that other ubiquitin ligases are also activated for pVHL degradation.
Liu
W
W
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA.
Xin
H
H
Eckert
D T
DT
Brown
J A
JA
Gnarra
J R
JR
D064173:Anaphase-Promoting Complex-Cyclosome; D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002453:Cell Cycle / Q000502:physiology; D015687:Cell Hypoxia / Q000502:physiology; D056744:Cyclin B1 / Q000378:metabolism; D015536:Down-Regulation; D006367:HeLa Cells; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D043743:Ubiquitin-Protein Ligase Complexes / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D006623:von Hippel-Lindau Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology*
D056744:Cyclin B1; D043743:Ubiquitin-Protein Ligase Complexes; D064173:Anaphase-Promoting Complex-Cyclosome; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein
Hum Mutat. 2000;15(1):86-94
10612827
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11661-6
9751722
Mol Cell. 2001 Nov;8(5):1027-39
11741538
Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s
17255293
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1387-92
11171960
Nat Cell Biol. 2009 Aug;11(8):994-1001
19620968
Mutat Res. 2005 Oct 15;578(1-2):23-32
15998523
Nat Cell Biol. 2008 Mar;10(3):361-9
18297059
Exp Cell Res. 2008 Jun 10;314(10):2016-27
18420194
Trends Cell Biol. 2004 Jul;14(7):331-4
15246424
EMBO J. 2001 Nov 15;20(22):6499-508
11707420
Blood. 2009 Sep 3;114(10):2015-9
19494350
Acta Physiol (Oxf). 2009 Feb;195(2):205-30
18764866
EMBO J. 2004 Apr 7;23(7):1619-26
15029244
J Biol Chem. 2001 Mar 16;276(11):7919-26
11112789
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8817-22
9671762
Nat Med. 2006 Jul;12(7):809-16
16819549
Biochim Biophys Acta. 2008 Sep;1786(1):49-59
18544349
Annu Rev Biochem. 2005;74:115-28
15952883
Genes Dev. 2001 Sep 15;15(18):2396-407
11562349
Br J Cancer. 2004 Mar 22;90(6):1235-43
15026807
Nat Rev Cancer. 2008 Nov;8(11):865-73
18923434
EMBO J. 2004 May 5;23(9):1949-56
15071503
Nat Cell Biol. 2007 May;9(5):588-95
17450132
Carcinogenesis. 2008 Feb;29(2):263-72
18174259
Annu Rev Biochem. 2009;78:399-434
19489725
Mol Cell Biol. 2007 Apr;27(8):2967-79
17283060
Nat Cell Biol. 2003 Jan;5(1):64-70
12510195
Cancer Biol Ther. 2004 Jun;3(6):492-7
15254394
Nat Rev Genet. 2009 Dec;10(12):821-32
19884889
Annu Rev Pathol. 2007;2:145-73
18039096
Mol Cell Biol. 1998 May;18(5):2845-54
9566903
Cell Mol Life Sci. 2007 Mar;64(5):589-600
17334950
Cell Cycle. 2009 May 1;8(9):1386-95
19342889
Nat Med. 1995 Aug;1(8):822-6
7585187
Oncogene. 2010 Jan 7;29(1):1-10
19826416
Nature. 2004 Mar 11;428(6979):194-8
15014503
PLoS Med. 2006 Mar;3(3):e47
16417408
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):993-8
9448273
Methods Mol Biol. 2005;296:157-66
15576930
Nat Rev Mol Cell Biol. 2007 May;8(5):379-93
17426725
Science. 1999 Apr 16;284(5413):455-61
10205047
Cancer Cell. 2007 Apr;11(4):335-47
17418410